These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 2879311

  • 1. Associations among plasma prolactin levels, tardive dyskinesia, and paranoia in treated schizophrenics: relevance to supersensitivity psychosis.
    Csernansky JG, Vinogradov S, Prosser E, Kaplan J, Berger PA, Hollister LE.
    Psychopharmacol Bull; 1986; 22(3):897-9. PubMed ID: 2879311
    [No Abstract] [Full Text] [Related]

  • 2. Possible associations among plasma prolactin levels, tardive dyskinesia, and paranoia in treated male schizophrenics.
    Csernansky JG, Prosser E, Kaplan J, Mahler E, Berger PA, Hollister LE.
    Biol Psychiatry; 1986 Jun; 21(7):632-42. PubMed ID: 2871874
    [Abstract] [Full Text] [Related]

  • 3. Supersensitivity psychosis and tardive dyskinesia: a survey in schizophrenic outpatients.
    Chouinard G, Annable L, Ross-Chouinard A.
    Psychopharmacol Bull; 1986 Jun; 22(3):891-6. PubMed ID: 2879310
    [No Abstract] [Full Text] [Related]

  • 4. Basic and clinical studies of neuroleptic-induced supersensitivity psychosis and dyskinesia.
    Diamond BI, Borison RL.
    Psychopharmacol Bull; 1986 Jun; 22(3):900-5. PubMed ID: 2879312
    [No Abstract] [Full Text] [Related]

  • 5. Effects of verapamil on tardive dyskinesia and psychosis in schizophrenic patients.
    Reiter S, Adler L, Angrist B, Peselow E, Rotrosen J.
    J Clin Psychiatry; 1989 Jan; 50(1):26-7. PubMed ID: 2562952
    [Abstract] [Full Text] [Related]

  • 6. Early phase II clinical trial of remoxipride in treatment of schizophrenia with measurements of prolactin and neuroleptic activity.
    Chouinard G.
    J Clin Psychopharmacol; 1987 Jun; 7(3):159-64. PubMed ID: 2885345
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Dogma disputed: is tardive dyskinesia due to postsynaptic dopamine receptor supersensitivity?
    Jeste DV, Wyatt RJ.
    J Clin Psychiatry; 1981 Dec; 42(12):455-7. PubMed ID: 6118358
    [Abstract] [Full Text] [Related]

  • 10. Neuroleptic-induced supersensitivity psychosis.
    Chouinard G, Jones BD, Annable L.
    Am J Psychiatry; 1978 Nov; 135(11):1409-10. PubMed ID: 30291
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Schizophrenic and paranoid disorders in the aged.
    Varner RV, Gaitz CM.
    Psychiatr Clin North Am; 1982 Apr; 5(1):107-18. PubMed ID: 6124954
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Neurochemical studies on tardive dyskinesia. I. Urinary homovanillic acid and plasma prolactin.
    Tripodianakis J, Markianos M, Garelis E.
    Biol Psychiatry; 1983 Mar; 18(3):337-45. PubMed ID: 6132625
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A neuroendocrine study of supersensitivity in tardive dyskinesia.
    Tamminga CA, Smith RC, Pandey G, Frohman LA, Davis JM.
    Arch Gen Psychiatry; 1977 Oct; 34(10):1199-203. PubMed ID: 911219
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.